New Report Covers Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Prostate Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Prostate Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

To access full report with TOC, please visit Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Scope

- Extensive coverage of the Prostate Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Prostate Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Prostate Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

3D Biomatrix, LLC 3D Signatures Inc A&G Pharmaceutical Inc Abbott Diagnostics Abnova Corp AccuTech LLC Acobiom Adaptive Biotechnologies Corp Advanced Marker Discovery SL Affinimark Technologies, Inc. AIT Austrian Institute of Technology GmbH Albert-Ludwigs-Universitat Freiburg Almac Diagnostics Ltd AltheaDx Inc Ambrilia Biopharma Inc Andro Diagnostics Armune BioScience, Inc. Arno Therapeutics Inc AroCell AB Arquer Diagnostics Ltd Arrayit Diagnostics, Inc. Atturos Aurelium BioPharma Inc. Bayer HealthCare AG Baylor College of Medicine Beckman Coulter Inc BioAffinity Technologies, Inc. Biocare Medical LLC Biocrates Life Sciences AG BioMark Diagnostics Inc. bioMerieux S.A. BioRap Technologies Ltd Biosceptre (Aust) Pty Ltd Biotron Ltd Blondin Bioscience, LLC Caldera Health Limited Cancer Genetics Inc Cancer Research Technology Ltd Caprion Biosciences Inc Caris Life Sciences Inc Cellanyx Diagnostics, Inc. CellMax Life Cellmid Ltd Cepheid Ceres Nanosciences Inc ChemImage Corporation Children's Hospital Boston China Sky One Medical Inc Chronix Biomedical Inc Cleveland Diagnostics Inc. CompanDX Ltd. Courtagen Life Sciences Inc CS-Keys, Inc. Cytosystems Ltd Detroit R&D, Inc. DiagnoCure Inc. Diaxonhit SA Egenix, Inc. Epic Sciences Inc Epigenomics AG Euclid Diagnostics LLC Eventus Diagnostics Inc Exiqon A/S Exosomics Siena SpA Fluxion Biosciences, Inc. French National Institute of Health and Medical Research Genomic Health Inc Georg-August-Universitat Gottingen Georgia Institute of Technology GILUPI Nanomedizin GlycoZym Hologic Inc Ikonisys Inc Imperial College London Inanovate (UK) Ltd. InterGenetics Inc Inverness Medical Canada Inc. IRIS International, Inc. IV Diagnostics, Inc. Janssen Biotech Inc John Hopkins University KineMed Inc MabCure Inc. MacroArray Technologies LLC Mayo Clinic US MDNA Life Sciences Inc MDxHealth SA Metabolomic Technologies Inc Metamark Genetics, Inc. Metanomics Health GmbH MetaStat Inc Micromedic Technologies Ltd Milagen, Inc. Minomic International Ltd Miraculins Inc Myriad Genetics Inc Nano Discovery Inc. NanoIVD Inc NeuroBioTex Inc. Northwestern University Novel Bio-spectrum Technologies, Inc. Nuclea Biotechnologies Inc. Numares GmbH NuView Life Sciences Inc Olympia Diagnostics, Inc Oncascan Limited Onconome, Inc. ONCOVEDA Cancer Research Center OncoVista Innovative Therapies Inc On-Q-ity, Inc. Ontario Institute for Cancer Research OPKO Health Inc Orion Genomics LLC Ortho-Clinical Diagnostics Inc Oryzon Genomics SA OTraces Inc. Panacea Pharmaceuticals Inc PharmaSeq, Inc. Precision Biologics Inc Predictive Biosciences Inc PrognosDx Health Inc Prostate Management Diagnostics, Inc Protagen AG Proteocyte Diagnostics Inc ProteoMediX AG Proteomika Proveri Inc. Qiagen NV Quanterix Corp RiboMed Biotechnologies Inc Roche Diagnostics International Ltd Roswell Park Cancer Institute Siamab Therapeutics Inc Siemens Healthcare GmbH Sienna Cancer Diagnostics Ltd Sividon Diagnostics GmbH Soricimed Biopharma Inc Source MDx Stage I Diagnostics, Inc. Target Discovery, Inc. The University of South Australia Transbiomed, SL Tyrian Diagnostics Ltd University of California Los Angeles University of Central Florida University of Chicago University of Colorado University of Connecticut University of Iowa University of Maryland, Baltimore University of Michigan University of Oslo University of Otago University of South Florida University of Strathclyde Uppsala University US Biomarkers Inc Vermillion Inc Vitatex Inc. Vitrimark, Inc. Vitruvian Biomedical, Inc. VolitionRX Ltd Yale University ZEUS Scientific Inc

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###